Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, Riad El-Solh, Beirut, Lebanon.
Int J Antimicrob Agents. 2013 Jan;41(1):75-9. doi: 10.1016/j.ijantimicag.2012.08.010. Epub 2012 Nov 9.
A recent increase in carbapenem resistance among extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli isolates at a major tertiary care centre in Lebanon prompted the initiation of this study. Consecutive ESBL-producing isolates were tested for resistance to carbapenems, with initial screening by disk diffusion and Etest using ertapenem. The modified Hodge test was also performed. PCR of β-lactamase-encoding genes, including bla(NDM-1), bla(KPC), bla(OXA-48), bla(CTX-M), bla(TEM), bla(SHV), bla(CMY-2) and bla(OXA-1), as well as outer membrane porin genes (ompC and ompF) was performed. Sequencing, efflux pump inhibitor tests and random amplified polymorphic DNA (RAPD) analysis were performed. In total, 14 (2.45%) of 572 K. pneumoniae and 24 (1.07%) of 2243 E. coli were ertapenem-non-susceptible [minimum inhibitory concentration (MIC) ≥0.25 μg/mL]. Resistance to other carbapenems was variable. PCR and sequencing analysis revealed that isolates harboured different β-lactamase genes, including bla(OXA-1), bla(CTX-M-15), bla(TEM-1), bla(CMY-2), bla(OXA-48) and bla(NDM-1). In addition, K. pneumoniae lacked the outer membrane porin-encoding genes, whilst E. coli harboured them with detected mutations. CTX-M-15 was carried on a 90 kb plasmid, whilst OXA-48 was carried on a 70 kb plasmid. Efflux pump inhibition significantly decreased MICs in E. coli. RAPD analysis demonstrated genomic variability. In conclusion, carbapenem resistance in ESBL-producing K. pneumoniae and E. coli is due to the combined effect of β-lactamases with porin impermeability and/or efflux pump activity observed in these organisms, and in a number of isolates is due to the production of the carbapenemase-encoding genes bla(OXA-48) and the newly emerging bla(NDM-1).
在黎巴嫩的一家主要的三级保健中心,产超广谱β-内酰胺酶(ESBL)的肺炎克雷伯菌和大肠埃希菌分离株的碳青霉烯类耐药性最近有所增加,这促使开展了这项研究。对连续的产 ESBL 分离株进行了碳青霉烯类耐药性检测,初始筛选方法为纸片扩散法和使用厄他培南的 Etest。还进行了改良 Hodge 试验。对β-内酰胺酶编码基因(包括 bla(NDM-1)、bla(KPC)、bla(OXA-48)、bla(CTX-M)、bla(TEM)、bla(SHV)、bla(CMY-2)和 bla(OXA-1))以及外膜孔蛋白基因(ompC 和 ompF)进行了 PCR 检测。还进行了测序、外排泵抑制剂试验和随机扩增的多态性 DNA(RAPD)分析。在 572 株肺炎克雷伯菌中,有 14 株(2.45%)对厄他培南不敏感[最低抑菌浓度(MIC)≥0.25μg/mL];在 2243 株大肠埃希菌中,有 24 株(1.07%)对厄他培南不敏感。对其他碳青霉烯类的耐药性各不相同。PCR 和测序分析显示,分离株携带不同的β-内酰胺酶基因,包括 bla(OXA-1)、bla(CTX-M-15)、bla(TEM-1)、bla(CMY-2)、bla(OXA-48)和 bla(NDM-1)。此外,肺炎克雷伯菌缺乏外膜孔蛋白编码基因,而大肠埃希菌则携带这些基因并发现了突变。CTX-M-15 位于 90kb 质粒上,而 OXA-48 位于 70kb 质粒上。外排泵抑制剂的抑制作用显著降低了大肠埃希菌的 MIC 值。RAPD 分析显示了基因组的变异性。总之,产 ESBL 的肺炎克雷伯菌和大肠埃希菌对碳青霉烯类的耐药性是由于β-内酰胺酶与这些菌中观察到的孔蛋白通透性丧失和/或外排泵活性的共同作用所致,在一些分离株中还与碳青霉烯酶编码基因 bla(OXA-48)和新出现的 bla(NDM-1)的产生有关。